SGHTSight Sciences, Inc.

SGHT Stock Price, Valuation & Chart | Sight Sciences, Inc.

Compare

$8.420+0.23 (+2.81%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Devices SGHT intrinsic value SGHT calculated fair value vs price

Overview Financials Dividends Ratios

SGHT Historical price chart

SGHT Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization458.13M

PE Ratio-15.04

EPS-0.56

Trading Volume269.38K

Today's High/Low8.79/8.08

Dividend Yield0.00

52 Week High/Low9.24/3.19

Shares Outstanding54.41M

SGHT Financial Statement

SGHT Analyst ratings

SGHT Analysis & performance metrics

SGHT Company profile

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye…

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid…

SGHT Management team

Name

Position

Steve R. Tamayo Jr.

Vice President and Chief Ethics & Compliance Officer

Brenton Taylor

Executive Vice President of Operations

David Badawi M.D.CTO

Co-Founder, Chief Technology Officer & Director

Reay H. Brown M.D.

Chief Medical Officer

Manohar K. Raheja Ph.D.

Executive Vice President of Research & Development

Paul BadawiCEO

Co-Founder, President, Chief Executive Officer & Director

Alison Perry BauerleinCFO

Chief Financial Officer, Principal Financial & Accounting Officer and Treasurer

Jeremy B. Hayden J.D.

Chief Legal Officer & Corporate Secretary

Name

Position

Steve R. Tamayo Jr.

Vice President and Chief Ethics & Compliance Officer

Brenton Taylor

Executive Vice President of Operations

David Badawi M.D.CTO

Co-Founder, Chief Technology Officer & Director

Reay H. Brown M.D.

Chief Medical Officer

Manohar K. Raheja Ph.D.

Executive Vice President of Research & Development

Paul BadawiCEO

Co-Founder, President, Chief Executive Officer & Director

Alison Perry BauerleinCFO

Chief Financial Officer, Principal Financial & Accounting Officer and Treasurer

Jeremy B. Hayden J.D.

Chief Legal Officer & Corporate Secretary

Management Team

Steve R. Tamayo Jr.

Vice President and Chief Ethics & Compliance Officer

Brenton Taylor

Executive Vice President of Operations

David Badawi M.D.CTO

Co-Founder, Chief Technology Officer & Director

Reay H. Brown M.D.

Chief Medical Officer

Manohar K. Raheja Ph.D.

Executive Vice President of Research & Development

Paul BadawiCEO

Co-Founder, President, Chief Executive Officer & Director

Alison Perry BauerleinCFO

Chief Financial Officer, Principal Financial & Accounting Officer and Treasurer

Jeremy B. Hayden J.D.

Chief Legal Officer & Corporate Secretary

Management

Steve R. Tamayo Jr.

Vice President and Chief Ethics & Compliance Officer

Brenton Taylor

Executive Vice President of Operations

David Badawi M.D.CTO

Co-Founder, Chief Technology Officer & Director

Reay H. Brown M.D.

Chief Medical Officer

Manohar K. Raheja Ph.D.

Executive Vice President of Research & Development

Paul BadawiCEO

Co-Founder, President, Chief Executive Officer & Director

Alison Perry BauerleinCFO

Chief Financial Officer, Principal Financial & Accounting Officer and Treasurer

Jeremy B. Hayden J.D.

Chief Legal Officer & Corporate Secretary

Total 8 executives

SGHT Frequently asked questions

What is Sight Sciences, Inc. (SGHT) Stock Price?

Current stock price of Sight Sciences, Inc. (SGHT) stock is $8.420. The stock price is +2.81% higher in the session. The intraday range can be seen from this page. Volume of Sight Sciences, Inc. (SGHT) stock is 269.38K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Sight Sciences, Inc. (SGHT) stock price going up or down today?

The stock price of Sight Sciences, Inc. (SGHT) can change with earnings, company news, and overall market sentiment. Sight Sciences, Inc. operates in the Healthcare / Medical - Devices market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Sight Sciences, Inc. stock expensive at its current price?

Whether Sight Sciences, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for SGHT on this page is -15.04. EPS on this page is -0.56. Compare those figures with peers and growth expectations before deciding if the current Sight Sciences, Inc. price is justified.

How has the stock price of Sight Sciences, Inc. (SGHT) performed historically?

Historical performance for Sight Sciences, Inc. (SGHT) is shown on the price chart on this page. Review multi-period moves alongside volume to see how SGHT reacted to past earnings and market events.

Should I buy Sight Sciences, Inc. (SGHT) stock, at this price?

Buying Sight Sciences, Inc. (SGHT) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.